Published in J Exp Med on February 01, 1960
ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT. J Exp Med (1965) 15.47
Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. J Exp Med (1969) 7.43
ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT. J Exp Med (1963) 7.42
The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis. J Exp Med (1966) 6.50
RELATION OF A beta(1)-GLYCOPROTEIN OF HUMAN SERUM TO THE COMPLEMENT SYSTEM. J Exp Med (1960) 4.66
Acute poststreptococcal glomerulonephritis: immune deposit disease. J Clin Invest (1966) 4.64
Immunofluorescent localization of immunoglobulins, complement, and fibrinogen in human diseases. I. Systemic lupus erythematosus. J Clin Invest (1965) 4.55
The localization of in vivo bound complement in tissue section. J Exp Med (1962) 4.46
Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients. J Clin Invest (1967) 4.45
EXPERIMENTAL GLOMERULONEPHRITIS. IV. PARTICIPATION OF COMPLEMENT IN NEPHROTOXIC NEPHRITIS. J Exp Med (1964) 4.36
C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT. J Exp Med (1965) 4.23
Rheumatoid factor, complement, and conglutinin aberrations in patients with subacute bacterial endocarditis. J Clin Invest (1962) 3.96
Genetic polymorphism of the third component of human complement (C'3). J Clin Invest (1968) 3.10
Glomerular deposition of properdin in acute and chronic glomerulonephritis with hypocomplementemia. J Clin Invest (1971) 3.06
Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3. J Exp Med (1981) 2.88
SERUM LEVELS OF BETA-1C GLOBULIN, A COMPLEMENT COMPONENT, IN THE NEPHRITIDES, LIPOID NEPHROSIS, AND OTHER CONDITIONS. J Clin Invest (1964) 2.84
The selective inhibition of macrophage phagocytic receptors by anti-membrane antibodies. J Exp Med (1972) 2.51
Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator. J Exp Med (1973) 2.50
ACTION OF COMPLEMENT IN HEREDITARY ANGIONEUROTIC EDEMA: THE ROLE OF C'1-ESTERASE. J Clin Invest (1964) 2.50
Changes produced in mouse plasma proteins by acute bacterial infections. J Exp Med (1961) 2.41
Properdin anc C3 proactivator: alternate pathway components in human glomerulonephritis. J Clin Invest (1973) 2.33
Quantitative studies of immunofluorescent staining. I. Analyses of mixed immunofluorescence. Immunology (1967) 2.32
Hereditary deficiency of the second component of complement (C'2) in man. J Clin Invest (1966) 2.32
THE HEMOLYSIS OF RED CELLS FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA BY PARTIALLY PURIFIED SUB-COMPONENTS OF THE THIRD COMPLEMENT COMPONENT. J Clin Invest (1965) 2.29
Localization of the third component of complement on the cell wall of encapsulated Staphylococcus aureus M: implications for the mechanism of resistance to phagocytosis. Infect Immun (1979) 2.07
The nephrotic syndrome of childhood: immunologic, clinical, and pathologic correlations. J Clin Invest (1966) 1.96
SITES OF FORMATION OF IMMUNE GLOBULINS AND OF A COMPONENT OF C'(3): I. A NEW TECHNIQUE FOR THE DEMONSTRATION OF THE SYNTHESIS OF INDIVIDUAL SERUM PROTEINS BY TISSUES IN VITRO. J Exp Med (1961) 1.83
IDENTIFICATION OF THE COMPONENTS OF COMPLEMENT PARTICIPATING IN THE ANTIGLOBULIN REACTION. Immunology (1963) 1.76
Dichotomy between opsonization and serum complement activation by encapsulated staphylococci. Infect Immun (1978) 1.56
Normal serum cytotoxicity for P32-labeled smooth Enterobacteriaceae. 3. Isolation of a gammag normal antibody and characterization of other serum factors causing P32 loss. J Bacteriol (1966) 1.52
Membranoproliferative glomerulonephritis and persistent hypocomplementaemia. Br Med J (1970) 1.41
Chronic hemolytic anemia due to cold agglutinins: the mechanism of resistance of red cells to C' hemolysis by cold agglutinins. J Clin Invest (1967) 1.37
PROTEIN CONCENTRATION OF OEDEMA FLUID IN RHEUMATOID ARTHRITIS. II. Ann Rheum Dis (1965) 1.34
Formation of C'-6 by rabbit liver tissue in vitro. Immunology (1968) 1.24
Immunopathologic studies of systemic lupus erythematosus (SLE). I. Tissue-bound immunoglobulins in relation to serum antinuclear immunoglobulins in systemic lupus and in chronic liver disease with LE cell factor. J Clin Invest (1967) 1.22
Recent insights into C3 glomerulopathy. Nephrol Dial Transplant (2013) 1.21
Production of ultrastructural membrane lesions by the fifth component of complement. J Exp Med (1971) 1.18
SITES OF FORMATION OF IMMUNE GLOBULINS AND OF A COMPONENT OF C'(3): II. PRODUCTION OF IMMUNOELECTROPHORETICALLY IDENTIFIED SERUM PROTEINS BY HUMAN AND MONKEY TISSUES IN VITRO. J Exp Med (1961) 1.17
Effect of mercaptans and other agents on the human complement component beta-1c-globulin. Immunology (1966) 1.17
Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets. J Clin Invest (1970) 1.05
The antigenic and molecular alterations of C3 in the fluid phase during an immune reaction in normal human serum. Demonstration of a new conversion product, C3x. J Exp Med (1971) 1.03
Proteins adhering to Escherichia coli after exposure to guinea-pig serum. Immunology (1967) 1.00
Thymectomy and renal homotransplantation. Clin Exp Immunol (1970) 0.98
Rabbit C3 isolation and characterization of reactions in vitro and during in vivo antigen-antibody interaction. Immunology (1969) 0.94
Effect of rheumatoid factor on complement-mediated phagocytosis. J Clin Invest (1972) 0.88
Isolation of human beta1A-globulin by modern techniques. Biochem J (1969) 0.88
Detection of complement components on unlysed erythrocytes from acid hemolysis and thrombin test reactions in paroxysmal nocturnal hemoglobinuria. J Clin Invest (1966) 0.87
Complement and cold agglutinins. I. Complement coating of normal human erythrocytes by cold agglutinins. Clin Exp Immunol (1967) 0.86
Complement components in three pathological sera: relation to clinical states. Clin Exp Immunol (1966) 0.86
Serum-red cell interactions at low ionic strength: erythrocyte complement coating and hemolysis of paroxysmal nocturnal hemoglobinuria cells. J Clin Invest (1967) 0.85
Charge and size of the conversion products of serum beta-1C-globulin. Immunology (1967) 0.84
Serum C3 levels in acute glomerulonephritis and postnephritic children. Arch Dis Child (1973) 0.80
Estimation of beta-IG globulin in glomerulonephritis. Can Med Assoc J (1967) 0.79
Minor Role of Plasminogen in Complement Activation on Cell Surfaces. PLoS One (2015) 0.75
Current concepts in C3 glomerulopathy. Indian J Nephrol (2014) 0.75
Chemical and immunological characterization of a basement membrane-like glycoprotein in the rat. Ann Rheum Dis (1971) 0.75
[A micro-method of immuno-electrophoresis]. Int Arch Allergy Appl Immunol (1955) 52.23
The carbohydrate of gamma-globulin and myeloma proteins. J Exp Med (1956) 5.85
The effect of the antigen's molecular weight on the curvature of the precipitin line in the Ouchterlony technic. J Immunol (1957) 4.88
RELATION OF A beta(1)-GLYCOPROTEIN OF HUMAN SERUM TO THE COMPLEMENT SYSTEM. J Exp Med (1960) 4.66
A new supporting medium for preparative electrophoresis. Scand J Clin Lab Invest (1960) 7.20
The carbohydrate of gamma-globulin and myeloma proteins. J Exp Med (1956) 5.85
An unusual protein component of high molecular weight in the serum of certain patients with rheumatoid arthritis. J Exp Med (1957) 5.79
Gamma globulin complexes in rheumatoid arthritis and certain other conditions. J Clin Invest (1961) 5.62
Improved separation of serum proteins in paper electrophoresis: a new electrophoresis buffer. Scand J Clin Lab Invest (1957) 5.62
Isolation of a thermolabile serum protein which precipitates gamma-globulin aggregates and participates in immune hemolysis. Proc Soc Exp Biol Med (1961) 5.41
The localization of in vivo bound complement in tissue section. J Exp Med (1962) 4.46
Isolation and description of proteins related to the human complement system. Acta Soc Med Ups (1961) 3.98
Two types of gamma-globulin differing in carbohydrate content. Proc Soc Exp Biol Med (1956) 3.49
Anti-nuclear factors and serum complement in systemic lupus erythematosus. Bull N Y Acad Med (1962) 2.69
Studies on the isolation and characterization of the "rheumatoid factor". J Clin Invest (1959) 2.38
Relation of high molecular weight proteins to the serological reactions in rheumatoid arthritis. Ann Rheum Dis (1957) 2.13
Ultracentrifugal characteristics and carbohydrate content of macromolecular gamma-globulins. Clin Chim Acta (1959) 1.42
Electrophoretic separation of serum protein into twelve fractions. Scand J Clin Lab Invest (1958) 1.26
Two proteins of human serum related to the complement system. Ann N Y Acad Sci (1961) 0.87
GM CHARACTERS OF 7 S GAMMA-MYELOMA PROTEINS AND CORRESPONDING INDIVIDUAL NORMAL GAMMA-GLOBULINS. Acta Pathol Microbiol Scand (1964) 0.83
[Not Available]. Dtsch Med Wochenschr (1959) 0.79
ANTICOMPLEMENTARY EFFECT OF M-COMPONENTS. Acta Pathol Microbiol Scand (1963) 0.75
A simple apparatus for ultrafiltration. Scand J Clin Lab Invest (1957) 0.75
Electrophoretic protein and polysaccharide patterns in tuberculosis and amyloidosis. Clin Chim Acta (1959) 0.75
[Carbohydrate of gamma globulins in human serum]. Klin Wochenschr (1956) 0.75
A study of the periodic acid-Schiff method for staining of protein-bound serum polysaccharides. A modified method. Acta Soc Med Ups (1961) 0.75
Serological evidence of a chromatographic subfractionation of human 7S gamma-globulin. Nature (1961) 0.75
[The rheumatoid factor]. Rev Med Cubana (1960) 0.75